$RARX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Ra Pharmaceuticals, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Ra Pharmaceuticals, Inc.. Get notifications about new insider transactions in Ra Pharmaceuticals, Inc. for free.

Page: < prev 1 2 3 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 13 2019	RARX	Ra Pharmaceuticals ...	RA CAPITAL MANAGEMENT, LLC	Director	Option Exercise	A	19.88	15,000	298,200	15,000
Jun 13 2019	RARX	Ra Pharmaceuticals ...	Mathers Edward T	Director	Option Exercise	A	19.88	15,000	298,200	15,000
Apr 18 2019	RARX	Ra Pharmaceuticals ...	King John C	Chief Commercial Of ...	Option Exercise	M	0.00	15,329	0	30,658
Apr 18 2019	RARX	Ra Pharmaceuticals ...	King John C	Chief Commercial Of ...	Payment of Exercise	F	21.93	4,506	98,817	10,823	15.3 K to 10.8 K (-29.40 %)
Apr 18 2019	RARX	Ra Pharmaceuticals ...	King John C	Chief Commercial Of ...	Buy	M	0.00	15,329	0	15,329	0 to 15.3 K
Feb 05 2019	RARX	Ra Pharmaceuticals ...	King John C	Chief Commercial Of ...	Option Exercise	A	21.00	107,000	2,247,000	107,000
Feb 05 2019	RARX	Ra Pharmaceuticals ...	Lubner David Charles	Executive V.P. & CF ...	Option Exercise	M	0.00	10,417	0	20,833
Feb 05 2019	RARX	Ra Pharmaceuticals ...	Lubner David Charles	Executive V.P. & CF ...	Option Exercise	A	21.00	133,000	2,793,000	133,000
Feb 05 2019	RARX	Ra Pharmaceuticals ...	Lubner David Charles	Executive V.P. & CF ...	Payment of Exercise	F	21.00	3,291	69,111	7,126	10.4 K to 7.1 K (-31.59 %)
Feb 05 2019	RARX	Ra Pharmaceuticals ...	Lubner David Charles	Executive V.P. & CF ...	Buy	M	0.00	10,417	0	10,417	0 to 10.4 K
Feb 05 2019	RARX	Ra Pharmaceuticals ...	Read Simon	Chief Scientific Of ...	Option Exercise	M	0.00	9,167	0	18,333
Feb 05 2019	RARX	Ra Pharmaceuticals ...	Read Simon	Chief Scientific Of ...	Option Exercise	A	21.00	107,000	2,247,000	107,000
Feb 05 2019	RARX	Ra Pharmaceuticals ...	Read Simon	Chief Scientific Of ...	Payment of Exercise	F	21.00	2,933	61,593	6,234	9.2 K to 6.2 K (-32.00 %)
Feb 05 2019	RARX	Ra Pharmaceuticals ...	Read Simon	Chief Scientific Of ...	Buy	M	0.00	9,167	0	9,167	0 to 9.2 K
Feb 05 2019	RARX	Ra Pharmaceuticals ...	Farzaneh-Far Ramin	Chief Medical Offic ...	Option Exercise	M	0.00	10,417	0	20,833
Feb 05 2019	RARX	Ra Pharmaceuticals ...	Farzaneh-Far Ramin	Chief Medical Offic ...	Option Exercise	A	21.00	133,000	2,793,000	133,000
Feb 05 2019	RARX	Ra Pharmaceuticals ...	Farzaneh-Far Ramin	Chief Medical Offic ...	Payment of Exercise	F	21.00	3,285	68,985	7,132	10.4 K to 7.1 K (-31.53 %)
Feb 05 2019	RARX	Ra Pharmaceuticals ...	Farzaneh-Far Ramin	Chief Medical Offic ...	Buy	M	0.00	10,417	0	10,417	0 to 10.4 K
Feb 05 2019	RARX	Ra Pharmaceuticals ...	Treco Douglas A	President and CEO	Option Exercise	M	0.00	20,834	0	41,666
Feb 05 2019	RARX	Ra Pharmaceuticals ...	Treco Douglas A	President and CEO	Option Exercise	A	21.00	311,000	6,531,000	311,000
Feb 05 2019	RARX	Ra Pharmaceuticals ...	Treco Douglas A	President and CEO	Payment of Exercise	F	21.00	6,327	132,867	218,799	225.1 K to 218.8 K (-2.81 %)
Feb 05 2019	RARX	Ra Pharmaceuticals ...	Treco Douglas A	President and CEO	Buy	M	0.00	20,834	0	225,126	204.3 K to 225.1 K (+10.20 %)
Dec 14 2018	RARX	Ra Pharmaceuticals ...	NEW ENTERPRISE ASSOCIATES 13 L ...	10% Owner	Buy	P	15.50	645,161	9,999,996	6,135,234	5.5 M to 6.1 M (+11.75 %)
Dec 14 2018	RARX	Ra Pharmaceuticals ...	RA CAPITAL MANAGEMENT, LLC	Director	Buy	P	15.50	1,006,452	15,600,006	4,858,260	3.9 M to 4.9 M (+26.13 %)
Dec 14 2018	RARX	Ra Pharmaceuticals ...	Shah Rajeev M.	Director	Buy	P	15.50	1,006,452	15,600,006	4,858,260	3.9 M to 4.9 M (+26.13 %)
Nov 15 2018	RARX	Ra Pharmaceuticals ...	Cumbo Alexander	Director	Option Exercise	A	12.99	25,000	324,750	25,000
Nov 01 2018	RARX	Ra Pharmaceuticals ...	RA CAPITAL MANAGEMENT, LLC	Director	Option Exercise	A	9.90	15,000	148,500	15,000
Nov 01 2018	RARX	Ra Pharmaceuticals ...	RA CAPITAL MANAGEMENT, LLC	Director	Option Exercise	A	9.90	15,000	148,500	15,000
Sep 25 2018	RARX	Ra Pharmaceuticals ...	Brennan Aoife	Director	Option Exercise	A	16.36	25,000	409,000	25,000
Jul 02 2018	RARX	Ra Pharmaceuticals ...	RA CAPITAL MANAGEMENT, LLC	Director	Option Exercise	A	9.90	15,000	148,500	15,000
Jul 02 2018	RARX	Ra Pharmaceuticals ...	Mathers Edward T	Director	Option Exercise	A	9.90	15,000	148,500	15,000
Jul 02 2018	RARX	Ra Pharmaceuticals ...	Heft Robert	Director	Option Exercise	A	9.90	15,000	148,500	15,000
Jul 02 2018	RARX	Ra Pharmaceuticals ...	PEARSON TIMOTHY R	Director	Option Exercise	A	9.90	15,000	148,500	15,000
Jul 02 2018	RARX	Ra Pharmaceuticals ...	Bisgaard Peter	Director	Option Exercise	A	9.90	15,000	148,500	15,000
Jul 02 2018	RARX	Ra Pharmaceuticals ...	Shah Rajeev M.	Director	Option Exercise	A	9.90	15,000	148,500	15,000
May 02 2018	RARX	Ra Pharmaceuticals ...	King John C	Chief Commercial Of ...	Option Exercise	A	0.00	45,987	0	45,987
May 02 2018	RARX	Ra Pharmaceuticals ...	King John C	Chief Commercial Of ...	Option Exercise	A	6.20	190,000	1,178,000	190,000
Feb 16 2018	RARX	Ra Pharmaceuticals ...	Shah Rajeev M.	Director	Buy	P	6.00	2,500,000	15,000,000	3,851,808	1.4 M to 3.9 M (+184.94 %)
Feb 16 2018	RARX	Ra Pharmaceuticals ...	RA CAPITAL MANAGEMENT, LLC	Director	Buy	P	6.00	2,500,000	15,000,000	3,851,808	1.4 M to 3.9 M (+184.94 %)
Feb 05 2018	RARX	Ra Pharmaceuticals ...	Farzaneh-Far Ramin	Chief Medical Offic ...	Option Exercise	A	0.00	31,250	0	31,250
Feb 05 2018	RARX	Ra Pharmaceuticals ...	Farzaneh-Far Ramin	Chief Medical Offic ...	Option Exercise	A	7.33	62,500	458,125	62,500
Feb 05 2018	RARX	Ra Pharmaceuticals ...	Read Simon	Chief Scientific Of ...	Option Exercise	A	0.00	27,500	0	27,500
Feb 05 2018	RARX	Ra Pharmaceuticals ...	Read Simon	Chief Scientific Of ...	Option Exercise	A	7.33	55,000	403,150	55,000
Feb 05 2018	RARX	Ra Pharmaceuticals ...	Lubner David Charles	Executive V.P. & CF ...	Option Exercise	A	0.00	31,250	0	31,250
Feb 05 2018	RARX	Ra Pharmaceuticals ...	Lubner David Charles	Executive V.P. & CF ...	Option Exercise	A	7.33	62,500	458,125	62,500
Feb 05 2018	RARX	Ra Pharmaceuticals ...	Treco Douglas A	President and CEO	Option Exercise	A	0.00	62,500	0	62,500
Feb 05 2018	RARX	Ra Pharmaceuticals ...	Treco Douglas A	President and CEO	Option Exercise	A	7.33	125,000	916,250	125,000
Oct 30 2017	RARX	Ra Pharmaceuticals ...	Bisgaard Peter	Director	Option Exercise	A	22.37	15,000	335,550	15,000
Jun 22 2017	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	A	22.37	15,000	335,550	15,000
Jun 22 2017	RARX	Ra Pharmaceuticals ...	Mathers Edward T	Director	Option Exercise	A	22.37	15,000	335,550	15,000
Jun 22 2017	RARX	Ra Pharmaceuticals ...	Heft Robert	Director	Option Exercise	A	22.37	15,000	335,550	15,000
Jun 22 2017	RARX	Ra Pharmaceuticals ...	Shah Rajeev M.	Director	Option Exercise	A	22.37	15,000	335,550	15,000
Jun 22 2017	RARX	Ra Pharmaceuticals ...	PEARSON TIMOTHY R	Director	Option Exercise	A	22.37	15,000	335,550	15,000
Jun 22 2017	RARX	Ra Pharmaceuticals ...	RA CAPITAL MANAGEMENT, LLC	Director	Option Exercise	A	22.37	15,000	335,550	15,000
Jun 20 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	22.02	3,220	70,899	2,251,457	2.3 M to 2.3 M (-0.14 %)
Jun 20 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	21.24	53,200	1,130,207	2,254,677	2.3 M to 2.3 M (-2.31 %)
Jun 12 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	22.00	700	15,400	2,307,877	2.3 M to 2.3 M (-0.03 %)
Jun 08 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	22.11	4,840	106,999	2,308,577	2.3 M to 2.3 M (-0.21 %)
Jun 08 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	22.98	7,274	167,161	2,313,417	2.3 M to 2.3 M (-0.31 %)
Jun 06 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	23.11	4,780	110,488	2,320,691	2.3 M to 2.3 M (-0.21 %)
Jun 06 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	23.47	14,867	348,949	2,325,471	2.3 M to 2.3 M (-0.64 %)
Jun 02 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	23.89	10,722	256,176	2,340,338	2.4 M to 2.3 M (-0.46 %)
Jun 02 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	23.94	35,539	850,896	2,351,060	2.4 M to 2.4 M (-1.49 %)
May 25 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	25.01	17,451	436,364	2,391,952	2.4 M to 2.4 M (-0.72 %)
May 22 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	25.50	9,019	229,964	2,409,403	2.4 M to 2.4 M (-0.37 %)
May 18 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	25.51	22,534	574,901	2,418,422	2.4 M to 2.4 M (-0.92 %)
May 18 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	26.33	20,081	528,725	2,440,956	2.5 M to 2.4 M (-0.82 %)
May 02 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	20.91	7,778	162,658	2,461,037	2.5 M to 2.5 M (-0.32 %)
May 02 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	20.86	7,847	163,670	2,468,815	2.5 M to 2.5 M (-0.32 %)
May 02 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	20.96	57,844	1,212,306	2,476,662	2.5 M to 2.5 M (-2.28 %)
May 02 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	20.93	5,398	113,000	2,534,506	2.5 M to 2.5 M (-0.21 %)
May 02 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	21.04	4,999	105,160	2,539,904	2.5 M to 2.5 M (-0.20 %)
May 02 2017	RARX	Ra Pharmaceuticals ...	Novartis Bioventures Ltd	10% Owner	Sell	S	21.86	749	16,370	2,544,903	2.5 M to 2.5 M (-0.03 %)
Feb 03 2017	RARX	Ra Pharmaceuticals ...	Lubner David Charles	Executive V.P. & CF ...	Option Exercise	A	16.64	112,500	1,872,000	112,500
Feb 03 2017	RARX	Ra Pharmaceuticals ...	Farzaneh-Far Ramin	Chief Medical Offic ...	Option Exercise	A	16.64	90,000	1,497,600	90,000
Nov 02 2016	RARX	Ra Pharmaceuticals ...	Novo A/S	10% Owner	Option Exercise	C	0.00	860,438	0	0
Nov 02 2016	RARX	Ra Pharmaceuticals ...	Novo A/S	10% Owner	Option Exercise	C	0.00	924,970	0	0
Nov 02 2016	RARX	Ra Pharmaceuticals ...	Novo A/S	10% Owner	Buy	P	13.00	246,154	3,200,002	2,031,562	1.8 M to 2 M (+13.79 %)
Nov 02 2016	RARX	Ra Pharmaceuticals ...	Novo A/S	10% Owner	Buy	C	0.00	860,438	0	1,785,408	925 K to 1.8 M (+93.02 %)
Nov 02 2016	RARX	Ra Pharmaceuticals ...	Novo A/S	10% Owner	Buy	C	0.00	924,970	0	924,970	0 to 925 K
Oct 31 2016	RARX	Ra Pharmaceuticals ...	RA CAPITAL MANAGEMENT, LLC	Director	Option Exercise	C	0.00	4,015,378	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	RA CAPITAL MANAGEMENT, LLC	Director	Option Exercise	C	0.00	4,316,531	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	RA CAPITAL MANAGEMENT, LLC	Director	Buy	P	13.00	161,538	2,099,994	1,351,808	1.2 M to 1.4 M (+13.57 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	RA CAPITAL MANAGEMENT, LLC	Director	Buy	C	0.00	573,624	0	1,190,270	616.6 K to 1.2 M (+93.02 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	RA CAPITAL MANAGEMENT, LLC	Director	Buy	C	0.00	616,646	0	616,646	0 to 616.6 K
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Shah Rajeev M.	Director	Option Exercise	C	0.00	4,015,378	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Shah Rajeev M.	Director	Option Exercise	C	0.00	4,316,531	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Shah Rajeev M.	Director	Buy	P	13.00	161,538	2,099,994	1,351,808	1.2 M to 1.4 M (+13.57 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Shah Rajeev M.	Director	Buy	C	0.00	573,624	0	1,190,270	616.6 K to 1.2 M (+93.02 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Shah Rajeev M.	Director	Buy	C	0.00	616,646	0	616,646	0 to 616.6 K
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lubner David Charles	EVP & CFO	Option Exercise	A	2.87	29,285	84,048	29,285
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Weller Harry R	10% Owner	Option Exercise	C	0.00	4,362,472	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Weller Harry R	10% Owner	Option Exercise	C	0.00	4,689,657	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Weller Harry R	10% Owner	Option Exercise	C	0.00	12,447,605	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Weller Harry R	10% Owner	Option Exercise	X	0.07	80,658	5,646	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Weller Harry R	10% Owner	Buy	P	13.00	338,462	4,400,006	3,490,073	3.2 M to 3.5 M (+10.74 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Weller Harry R	10% Owner	Buy	C	0.00	623,210	0	3,151,611	2.5 M to 3.2 M (+24.65 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Weller Harry R	10% Owner	Buy	C	0.00	669,951	0	2,528,401	1.9 M to 2.5 M (+36.05 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Weller Harry R	10% Owner	Buy	C	0.00	1,778,227	0	1,858,450	80.2 K to 1.9 M (+2,216.60 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Weller Harry R	10% Owner	Sell	S	13.00	435	5,655	80,223	80.7 K to 80.2 K (-0.54 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Weller Harry R	10% Owner	Buy	X	0.07	80,658	5,646	80,658	0 to 80.7 K
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MORGENTHALER VENTURE PARTNERS ...	10% Owner	Option Exercise	C	0.00	3,408,439	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MORGENTHALER VENTURE PARTNERS ...	10% Owner	Option Exercise	C	0.00	3,664,071	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MORGENTHALER VENTURE PARTNERS ...	10% Owner	Option Exercise	C	0.00	9,744,916	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MORGENTHALER VENTURE PARTNERS ...	10% Owner	Option Exercise	X	0.07	63,019	4,411	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MORGENTHALER VENTURE PARTNERS ...	10% Owner	Buy	P	13.00	263,538	3,425,994	2,745,846	2.5 M to 2.7 M (+10.62 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MORGENTHALER VENTURE PARTNERS ...	10% Owner	Buy	C	0.00	486,919	0	2,482,308	2 M to 2.5 M (+24.40 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MORGENTHALER VENTURE PARTNERS ...	10% Owner	Buy	C	0.00	523,438	0	1,995,389	1.5 M to 2 M (+35.56 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MORGENTHALER VENTURE PARTNERS ...	10% Owner	Buy	C	0.00	1,392,130	0	1,471,951	79.8 K to 1.5 M (+1,744.06 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MORGENTHALER VENTURE PARTNERS ...	10% Owner	Sell	S	13.00	340	4,420	79,821	80.2 K to 79.8 K (-0.42 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	MORGENTHALER VENTURE PARTNERS ...	10% Owner	Buy	X	0.07	63,019	4,411	80,161	17.1 K to 80.2 K (+367.63 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Viswanathan Ravi	10% Owner	Option Exercise	C	0.00	4,362,472	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Viswanathan Ravi	10% Owner	Option Exercise	C	0.00	4,689,657	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Viswanathan Ravi	10% Owner	Option Exercise	C	0.00	12,447,605	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Viswanathan Ravi	10% Owner	Option Exercise	X	0.07	80,658	5,646	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Viswanathan Ravi	10% Owner	Buy	P	13.00	338,462	4,400,006	3,490,073	3.2 M to 3.5 M (+10.74 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Viswanathan Ravi	10% Owner	Buy	C	0.00	623,210	0	3,151,611	2.5 M to 3.2 M (+24.65 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Viswanathan Ravi	10% Owner	Buy	C	0.00	669,951	0	2,528,401	1.9 M to 2.5 M (+36.05 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Viswanathan Ravi	10% Owner	Buy	C	0.00	1,778,227	0	1,858,450	80.2 K to 1.9 M (+2,216.60 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Viswanathan Ravi	10% Owner	Sell	S	13.00	435	5,655	80,223	80.7 K to 80.2 K (-0.54 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Viswanathan Ravi	10% Owner	Buy	X	0.07	80,658	5,646	80,658	0 to 80.7 K
Oct 31 2016	RARX	Ra Pharmaceuticals ...	SANDELL SCOTT D	10% Owner	Option Exercise	C	0.00	4,362,472	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	SANDELL SCOTT D	10% Owner	Option Exercise	C	0.00	4,689,657	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	SANDELL SCOTT D	10% Owner	Option Exercise	C	0.00	12,447,605	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	SANDELL SCOTT D	10% Owner	Option Exercise	X	0.07	80,658	5,646	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	SANDELL SCOTT D	10% Owner	Buy	P	13.00	338,462	4,400,006	3,490,073	3.2 M to 3.5 M (+10.74 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	SANDELL SCOTT D	10% Owner	Buy	C	0.00	623,210	0	3,151,611	2.5 M to 3.2 M (+24.65 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	SANDELL SCOTT D	10% Owner	Buy	C	0.00	669,951	0	2,528,401	1.9 M to 2.5 M (+36.05 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	SANDELL SCOTT D	10% Owner	Buy	C	0.00	1,778,227	0	1,858,450	80.2 K to 1.9 M (+2,216.60 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	SANDELL SCOTT D	10% Owner	Sell	S	13.00	435	5,655	80,223	80.7 K to 80.2 K (-0.54 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	SANDELL SCOTT D	10% Owner	Buy	X	0.07	80,658	5,646	80,658	0 to 80.7 K
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	C	0.00	481,503	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	C	0.00	3,533,875	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	C	0.00	517,617	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	C	0.00	3,798,914	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	C	0.00	3,408,439	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	C	0.00	3,664,071	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	C	0.00	9,744,916	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	X	0.07	63,019	4,411	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	P	13.00	15,633	203,229	4,066,503	4.1 M to 4.1 M (+0.39 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	P	13.00	114,752	1,491,776	4,050,870	3.9 M to 4.1 M (+2.92 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	P	13.00	263,538	3,425,994	3,936,118	3.7 M to 3.9 M (+7.18 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	C	0.00	68,786	0	3,672,580	3.6 M to 3.7 M (+1.91 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	C	0.00	504,839	0	3,603,794	3.1 M to 3.6 M (+16.29 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	C	0.00	73,945	0	3,098,955	3 M to 3.1 M (+2.44 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	C	0.00	542,702	0	3,025,010	2.5 M to 3 M (+21.86 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	C	0.00	486,919	0	2,482,308	2 M to 2.5 M (+24.40 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	C	0.00	523,438	0	1,995,389	1.5 M to 2 M (+35.56 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	C	0.00	1,392,130	0	1,471,951	79.8 K to 1.5 M (+1,744.06 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Sell	S	13.00	340	4,420	79,821	80.2 K to 79.8 K (-0.42 %)

Page: < prev 1 2 3 next >